1. Luo, Zimian, Yin, Yafei, Tan, Xiaojun, Chao, Zhi, Xia, Hong. 2021. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis. In Leukemia research, 113, 106774. doi:10.1016/j.leukres.2021.106774. https://pubmed.ncbi.nlm.nih.gov/35030455/
2. Schlevogt, Bernhard, Schlieper, Vincent, Krader, Jana, Nedvetsky, Pavel I, Krahn, Michael P. 2022. A SEC61A1 variant is associated with autosomal dominant polycystic liver disease. In Liver international : official journal of the International Association for the Study of the Liver, 43, 401-412. doi:10.1111/liv.15493. https://pubmed.ncbi.nlm.nih.gov/36478640/
3. Schubert, Desirée, Klein, Marie-Christine, Hassdenteufel, Sarah, Zimmermann, Richard, Grimbacher, Bodo. 2017. Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). In The Journal of allergy and clinical immunology, 141, 1427-1438. doi:10.1016/j.jaci.2017.06.042. https://pubmed.ncbi.nlm.nih.gov/28782633/
4. Van Nieuwenhove, Erika, Barber, John S, Neumann, Julika, Meyts, Isabelle, Liston, Adrian. 2020. Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia. In The Journal of allergy and clinical immunology, 146, 1180-1193. doi:10.1016/j.jaci.2020.03.034. https://pubmed.ncbi.nlm.nih.gov/32325141/